Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [14]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60170-1-Ig - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#60170-1-Ig, RRID:AB_10694834
- Product name
- TEM1 antibody
- Antibody type
- Monoclonal
- Description
- TEM1 antibody (Cat. #60170-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1F9B4
- Vial size
- 20ul, 150ul
Submitted references Understanding Glioblastoma Dynamics Using 3D Organoids and Engineered Extracellular Matrix.
Understanding proneural-mesenchymal transition using patient-derived glioma stem-like cell (GSC) organoids and engineered extracellular matrix.
Expression of antibody-drug conjugate targets in soft tissue sarcomas.
iRGD-modified co-loaded curcumin piperine liposomes inhibit angiogenesis in non-small cell lung cancer through the VEGFR2/P38/MK2 signaling axis.
Lipid infiltration promotes trans-differentiation of vascular smooth muscle cells into macrophage-like cells in early lesions of human coronary atherosclerosis.
Mesangial angiogenesis and interstitial eosinophilic infiltration in diabetic nephropathy are associated with elevated CD248 expression.
Dynamic molecular atlas of cardiac fibrosis at single-cell resolution shows CD248 in cardiac fibroblasts orchestrates interactions with immune cells.
CD248 promotes insulin resistance by binding to the insulin receptor and dampening its insulin-induced autophosphorylation.
Targeted therapies of inflammatory diseases with intracellularly gelated macrophages in mice and rats.
Soluble tumor endothelial marker 1 in heart failure with reduced ejection fraction: A pilot study.
CD248 Regulates Wnt Signaling in Pericytes to Promote Angiogenesis and Tumor Growth in Lung Cancer.
Tumor endothelial marker 1 is upregulated in heart after cardiac injury and participates in cardiac remodeling.
A membrane protein display platform for receptor interactome discovery.
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma.
McManis A, Jimenez CA, Shirolkar A, Raza Ur Rehman S, Mallick S, Murphy M, Gaharwar AK, Singh I
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Apr;13(24):e22926
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Apr;13(24):e22926
Understanding proneural-mesenchymal transition using patient-derived glioma stem-like cell (GSC) organoids and engineered extracellular matrix.
McManis A, Jimenez CA, Shirolkar A, Rehman SRU, Mallick S, Murphy M, Gaharwar AK, Singh I
bioRxiv : the preprint server for biology 2025 Sep 20;
bioRxiv : the preprint server for biology 2025 Sep 20;
Expression of antibody-drug conjugate targets in soft tissue sarcomas.
Bertucci F, Finetti P, Mescam L, Monneur A, Frejafon A, Le Cesne A, Treilleux I, Italiano A, Brahmi M, Blay JY, Mamessier E
ESMO open 2025 Oct;10(10):105837
ESMO open 2025 Oct;10(10):105837
iRGD-modified co-loaded curcumin piperine liposomes inhibit angiogenesis in non-small cell lung cancer through the VEGFR2/P38/MK2 signaling axis.
Huang X, Chen Y, Chen J, Lin J, Zhuang Y, Huang M, Yu H, Wang M, Wang Y, Wang Y
Discover oncology 2025 Nov 7;16(1):2056
Discover oncology 2025 Nov 7;16(1):2056
Lipid infiltration promotes trans-differentiation of vascular smooth muscle cells into macrophage-like cells in early lesions of human coronary atherosclerosis.
Hao J, Liu J, Zhou J, Liang Y, Chen W, Wu Y, Lin Z
Lipids in health and disease 2025 Jul 14;24(1):239
Lipids in health and disease 2025 Jul 14;24(1):239
Mesangial angiogenesis and interstitial eosinophilic infiltration in diabetic nephropathy are associated with elevated CD248 expression.
Li X, Zhang J, Wang Y, Yu T, Jiang S, Gao Y, Zhang H, Li W
Renal failure 2025 Dec;47(1):2510552
Renal failure 2025 Dec;47(1):2510552
Dynamic molecular atlas of cardiac fibrosis at single-cell resolution shows CD248 in cardiac fibroblasts orchestrates interactions with immune cells.
Li G, Ni C, Wang J, Zhang F, Fu Z, Wang L, Wang B, Liu Y, Zhao J, Li M, Lin H, Liao F, Ye S, Zhang Y, Cai J, Shi S, Zhong Z, Shi Y, He J, Xiong X, Xu Y, Chen J, Zhu W, Wang Y, Wang J, Hu X
Nature cardiovascular research 2025 Apr;4(4):380-396
Nature cardiovascular research 2025 Apr;4(4):380-396
CD248 promotes insulin resistance by binding to the insulin receptor and dampening its insulin-induced autophosphorylation.
Benedet PO, Safikhan NS, Pereira MJ, Lum BM, Botezelli JD, Kuo CH, Wu HL, Craddock BP, Miller WT, Eriksson JW, Yue JTY, Conway EM
EBioMedicine 2024 Jan;99:104906
EBioMedicine 2024 Jan;99:104906
Targeted therapies of inflammatory diseases with intracellularly gelated macrophages in mice and rats.
Gao C, Wang Q, Ding Y, Kwong CHT, Liu J, Xie B, Wei J, Lee SMY, Mok GSP, Wang R
Nature communications 2024 Jan 6;15(1):328
Nature communications 2024 Jan 6;15(1):328
Soluble tumor endothelial marker 1 in heart failure with reduced ejection fraction: A pilot study.
Feng WH, Chen PS, Chung HC, Lin YH, Li YH
Frontiers in cardiovascular medicine 2022;9:1015471
Frontiers in cardiovascular medicine 2022;9:1015471
CD248 Regulates Wnt Signaling in Pericytes to Promote Angiogenesis and Tumor Growth in Lung Cancer.
Hong CL, Yu IS, Pai CH, Chen JS, Hsieh MS, Wu HL, Lin SW, Huang HP
Cancer research 2022 Oct 17;82(20):3734-3750
Cancer research 2022 Oct 17;82(20):3734-3750
Tumor endothelial marker 1 is upregulated in heart after cardiac injury and participates in cardiac remodeling.
Chen PS, Feng WH, Tsai TH, Hong YK, Lee AS, Chang KC, Chung HC, Liu YW, Hsieh CC, Fang YH, Yang PJ, Luo CY, Liu PY, Cheng TL, Li YH
Scientific reports 2022 Jun 22;12(1):10532
Scientific reports 2022 Jun 22;12(1):10532
A membrane protein display platform for receptor interactome discovery.
Cao S, Peterson SM, Müller S, Reichelt M, McRoberts Amador C, Martinez-Martin N
Proceedings of the National Academy of Sciences of the United States of America 2021 Sep 28;118(39)
Proceedings of the National Academy of Sciences of the United States of America 2021 Sep 28;118(39)
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma.
Capone E, Piccolo E, Fichera I, Ciufici P, Barcaroli D, Sala A, De Laurenzi V, Iacobelli V, Iacobelli S, Sala G
Oncotarget 2017 Sep 1;8(36):60368-60377
Oncotarget 2017 Sep 1;8(36):60368-60377
No comments: Submit comment
No validations: Submit validation data